Revvity, Inc. (RVTY)
(Delayed Data from NYSE)
$111.89 USD
-0.78 (-0.69%)
Updated May 23, 2024 04:00 PM ET
After-Market: $111.90 +0.01 (0.01%) 6:18 PM ET
3-Hold of 5 3
C Value D Growth C Momentum D VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
RVTY 111.89 -0.78(-0.69%)
Will RVTY be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for RVTY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RVTY
Company News for Apr 30, 2024
Revvity (RVTY) Q1 Earnings and Revenues Surpass Estimates
RVTY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Revvity (RVTY) Reports Q1 Earnings: What Key Metrics Have to Say
Revvity (RVTY) Beats Q1 Earnings and Revenue Estimates
Revvity's (RVTY) New Launch to Boost Tuberculosis Testing
Other News for RVTY
Lab Instrument Industry Update - New Commercial Entrants
Commit To Buy Revvity At $105, Earn 10% Annualized Using Options
RVTY Makes Bullish Cross Above Critical Moving Average
Goldman’s top 50 Weak Balance Sheet stocks
4 Analysts Have This To Say About Revvity